RE: Antares pharma17 Feb 2019 08:11
the actual delay will depend entirely on what the perceived problem is,the FDAs requirements to address the same and Motifs response to the FDAs requirements.it could be a lot less than 12 months.still not good of course but maybe much less of a problem than we may have been fearing.we simply have to wait for the detail.